Cargando…
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial
BACKGROUND: Current rheumatoid arthritis therapies target immune inflammation and are subject to ceiling effects. Seliciclib is an orally available cyclin-dependent kinase inhibitor that suppresses proliferation of synovial fibroblasts—cells not yet targeted in rheumatoid arthritis. Part 1 of this p...
Autores principales: | Pratt, Arthur G, Siebert, Stefan, Cole, Michael, Stocken, Deborah D, Yap, Christina, Kelly, Stephen, Shaikh, Muddassir, Cranston, Amy, Morton, Miranda, Walker, Jenn, Frame, Sheelagh, Ng, Wan-Fai, Buckley, Christopher D, McInnes, Iain B, Filer, Andrew, Isaacs, John D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062952/ https://www.ncbi.nlm.nih.gov/pubmed/33928262 http://dx.doi.org/10.1016/S2665-9913(21)00061-8 |
Ejemplares similares
-
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial
por: Siebert, Stefan, et al.
Publicado: (2020) -
TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis
por: Cole, M., et al.
Publicado: (2021) -
Trafic induced by the LEP dismantling.
por: Margot Frenot
Publicado: (2000) -
Patient and researcher perspectives on facilitating patient and public involvement in rheumatology research
por: Pollock, Judith, et al.
Publicado: (2016) -
Overall maximum road trafic induced by the construction of LHC.
por: Serge Dailler
Publicado: (1997)